Johan Maervoet, PhD, MBA

Johan has over 10 years of experience providing advice on health economic modelling and pharmaceutical market access to clients in the life sciences industry. He has primarily focused on the design and development of economic models in therapeutic areas including oncology, ophthalmology, cardiovascular, musculoskeletal, respiratory, infectious and orphan diseases.

Johan has also been conducting indication-specific HTA landscape assessments and leading broad-scope market access engagements (including PRO/COA analysis, SLR, NMA/ITC, CE model design, core value dossiers, up to HTA submissions).

Work Experience

Johan started his career in academic / Phase I clinical research and worked for a few years as a Qualified Person before moving into management consulting. Prior to joining Parexel in 2019, he gained experience in the pharmaceutical practices of McKinsey & Co, Deloitte and IQVIA.

Education

Johan holds a PhD in pharmaceutical sciences (Antwerp University, Belgium), MBA (Vlerick Business School, Belgium) and the European Market Access University Diploma (EMAUD, Lyon, France). In addition, he has attended several expert classes on advanced health economic modelling methods (Universities of Brussels, York and Glasgow).